AbelZeta is a global clinical-stage biopharmaceutical company with centers of excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focusing on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body's own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances research and development in its own GMP facilities at its centers of excellence for early-stage clinical studies, with a pipeline comprised of CAR-T and TIL therapies. 

Biotechnology

Health Care

Pharmaceutical

Therapeutics

AbelZeta

Tony Liu

Cherie S.

Hui Wan

Jiaqi Huang

Andrew Chan

The Research and Development team at AbelZeta is dedicated to the innovation and advancement of cell-based therapeutic products. This diverse team of scientists and specialists engages in process development, quality control, translational medicine, and regulatory program management to drive early-stage clinical studies and develop cutting-edge CAR-T and TIL therapies. Their work is pivotal in transforming scientific discoveries into viable treatments for hematological malignancies, solid tumors, and immunological diseases.

Research and Development

Operations Team

Leadership Team

Research and Development

About

Team members

Other teams at AbelZeta

Operations Team

Leadership Team